Electroencephalographic Features of Elderly Patients during Anesthesia Induction with Remimazolam: A Substudy of a Randomized Controlled Trial

被引:1
|
作者
Kim, Hyoungkyu [1 ]
Min, Byoung-Kyong [2 ]
Lee, UnCheol [3 ]
Sim, Ji-Hoon [4 ]
Noh, Gyu-Jeong [4 ,5 ]
Lee, Eun-Kyung [6 ]
Choi, Byung-Moon [4 ]
机构
[1] Sungkyunkwan Univ, Inst Basic Sci IBS, Ctr Neurosci Imaging Res, Suwon, South Korea
[2] Korea Univ, Dept Brain & Cognit Engn, Seoul, South Korea
[3] Univ Michigan, Med Sch, Dept Anesthesiol, Ctr Consciousness Sci,Ctr Study Complex Syst, Ann Arbor, MI 48109 USA
[4] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Anesthesiol & Pain Med, Seoul, South Korea
[5] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Clin Pharmacol & Therapeut, Seoul, South Korea
[6] Ewha Womans Univ, Dept Stat, Seoul, South Korea
基金
新加坡国家研究基金会;
关键词
BISPECTRAL INDEX; PROPOFOL; AGE; PHARMACOKINETICS; CONSCIOUSNESS; COMMUNICATION; CONNECTIVITY; REMIFENTANIL; MODEL;
D O I
10.1097/ALN.0000000000004904
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
Background: Although remimazolam is used as a general anesthetic in elderly patients due to its hemodynamic stability, the electroencephalogram characteristics of remimazolam are not well known. The purpose of this study was to identify the electroencephalographic features of remimazolam-induced unconsciousness in elderly patients and compare them with propofol. Methods: Remimazolam (n = 26) or propofol (n = 26) were randomly administered for anesthesia induction in surgical patients. The hypnotic agent was blinded only to the patients. During the induction of anesthesia, remimazolam was administered at a rate of 6 mg <middle dot> kg(-1) <middle dot> h(-1), and propofol was administered at a target effect-site concentration of 3.5 mu g/ml. The electroencephalogram signals from eight channels (Fp1, Fp2, Fz, F3, F4, Pz, P3, and P4, referenced to A2, using the 10 to 20 system) were acquired during the induction of anesthesia and in the postoperative care unit. Power spectrum analysis was performed, and directed functional connectivity between frontal and parietal regions was evaluated using normalized symbolic transfer entropy. Functional connectivity in unconscious processes induced by remimazolam or propofol was compared with baseline. To compare each power of frequency over time of the two hypnotic agents, a permutation test with t statistic was conducted. Results: Compared to the baseline in the alpha band, the feedback connectivity decreased by averages of 46% and 43%, respectively, after the loss of consciousness induced by remimazolam and propofol (95% CI for the mean difference: -0.073 to -0.044 for remimazolam [P < 0.001] and -0.068 to -0.042 for propofol [P < 0.001]). Asymmetry in the feedback and feedforward connectivity in the alpha band was suppressed after the loss of consciousness induced by remimazolam and propofol. There were no significant differences in the power of each frequency over time between the two hypnotic agents (minimum q value = 0.4235). Conclusions: Both regimens showed a greater decrease in feedback connectivity compared to a decrease in feedforward connectivity after loss of consciousness, leading to a disruption of asymmetry between the frontoparietal connectivity.
引用
收藏
页码:681 / 692
页数:12
相关论文
共 50 条
  • [41] Comparison of remimazolam and sevoflurane for general anesthesia during transcatheter aortic valve implantation: a randomized trial
    Harimochi, So
    Godai, Kohei
    Nakahara, Mayumi
    Matsunaga, Akira
    CANADIAN JOURNAL OF ANESTHESIA-JOURNAL CANADIEN D ANESTHESIE, 2024,
  • [42] The incidences of nausea and vomiting after general anesthesia with remimazolam versus sevoflurane: a prospective randomized controlled trial
    Yoo, Yeong Min
    Park, Jae Hong
    Lee, Ki Hwa
    Yi, Ah Hyeon
    Kim, Tae Kyun
    KOREAN JOURNAL OF ANESTHESIOLOGY, 2024, 77 (04) : 441 - 449
  • [43] Remimazolam Compared to Propofol for Total Intravenous Anesthesia with Remifentanil on the Recovery of Psychomotor Function: A Randomized Controlled Trial
    Shimizu, Takahito
    Takasusuki, Toshifumi
    Yamaguchi, Shigeki
    ADVANCES IN THERAPY, 2023, 40 (10) : 4395 - 4404
  • [44] Remimazolam Compared to Propofol for Total Intravenous Anesthesia with Remifentanil on the Recovery of Psychomotor Function: A Randomized Controlled Trial
    Takahito Shimizu
    Toshifumi Takasusuki
    Shigeki Yamaguchi
    Advances in Therapy, 2023, 40 : 4395 - 4404
  • [45] Comparison of the bispectral indices of patients receiving remimazolam and propofol for general anesthesia: a randomized crossover trial
    Yang, Chen
    Jiao, Jing
    Nie, Yuyan
    Shao, Wenyu
    Zhang, Hongwei
    Huang, Shaoqiang
    ANAESTHESIA CRITICAL CARE & PAIN MEDICINE, 2024, 43 (03)
  • [46] Comparison of different weight-based scalars of remimazolam tosylate for anesthesia induction in obese patients: study protocol for a prospective, controlled trial
    Wenwen Ni
    Xiuwen Yi
    Lili Feng
    Yilei Shen
    Jiali Jiao
    Yirong Cai
    Danyun Fu
    Yuan Han
    Ji’e Jia
    Wenxian Li
    Trials, 24
  • [47] Comparison of different weight-based scalars of remimazolam tosylate for anesthesia induction in obese patients: study protocol for a prospective, controlled trial
    Ni, Wenwen
    Yi, Xiuwen
    Feng, Lili
    Shen, Yilei
    Jiao, Jiali
    Cai, Yirong
    Fu, Danyun
    Han, Yuan
    Jia, Ji'e
    Li, Wenxian
    TRIALS, 2023, 24 (01)
  • [48] Etomidate Combined with Propofol versus Remimazolam for Sedation in Elderly Patients During Gastrointestinal Endoscopy: A Randomized Prospective Clinical Trial
    Zhang, Qin
    Zhao, Rui
    Wu, Yaqing
    Zhang, Liming
    Feng, Yi
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2024, 18 : 2681 - 2692
  • [49] Dezocine in patients during recovery after anesthesia for thoracotomy: a prospective randomized controlled trial
    Cai, Qinfang
    Gu, Xiaofei
    Li, Jun
    Zhang, Zhe
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2016, 9 (02): : 5077 - 5082
  • [50] Pretreatment with Nalbuphine Prevents Sufentanil-Induced Cough During the Anesthesia Induction: A Randomized Controlled Trial
    Wang, Jiang
    Duan, Jinjuan
    Wang, Qiuyue
    Lu, Yao
    THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2020, 16 : 281 - 286